Allen Mooney & Barnes Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Allen Mooney & Barnes Investment Advisors's ABBV Position: Q2 2026 in Review
Allen Mooney & Barnes Investment Advisors reduced its AbbVie (ABBV) stake by 6.9% in Q2 2026, selling an estimated $1.3M and leaving 81,986 shares worth $20.6M. The position accounts for 3.14% of the portfolio, ranked #3.
Allen Mooney & Barnes Investment Advisors first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 2,137 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors held 81,986 shares of AbbVie worth $20.6M as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors sold 6,063 AbbVie shares in Q2 2026, an estimated $1.3M.
- AbbVie made up 3.14% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #3 holding.
- Allen Mooney & Barnes Investment Advisors first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
- 2,137 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.